Dysregulation of Mfn2 and Drp-1 proteins in heart failure

Author： Givvimani Srikanth   Pushpakumar Sathnur   Veeranki Sudhakar   Tyagi Suresh C.  

Publisher： NRC Research Press

ISSN： 1205-7541

Source： Canadian Journal of Physiology and Pharmacology, Vol.92, Iss.7, 2014-01, pp. : 583-591

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Ca2+-Handling Proteins and Heart Failure: Novel Molecular Targets?

By  

Current Medicinal Chemistry, Vol. 10, Iss. 11, 2003-06 ,pp. : 967-981

Bentham Science Publishers

Access to resources Recommend Favorite

Drp1 in Ischemic Neuronal Death: An Unusual Suspect

By  

Current Medicinal Chemistry, Vol. 21, Iss. 19, 2014-06 ,pp. : 2183-2189

Bentham Science Publishers

Access to resources Recommend Favorite

The GH/IGF-1 Axis in Chronic Heart Failure

By  

Endocrine, Metabolic & Immune Disorders-Drug Targets (Formerly Current Drug Targets - Immune, Endocrine & Metabolic Disorders), Vol. 13, Iss. 1, 2013-01 ,pp. : 76-91

Bentham Science Publishers

Access to resources Recommend Favorite

Neuregulin1 as Novel Therapy for Heart Failure

By  

Current Pharmaceutical Design, Vol. 17, Iss. 18, 2011-06 ,pp. : 1808-1817

Bentham Science Publishers

Access to resources Recommend Favorite

V2 receptor antagonism with tolvaptan in heart failure

By Costello-Boerrigter Lisa C   Boerrigter Guido   Burnett John C  

Expert Opinion on Investigational Drugs, Vol. 16, Iss. 10, 2007-10 ,pp. : 1639-1647

Informa Healthcare

Access to resources Recommend Favorite